Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zirconium-89 Certolizumab PET Imaging in Patients With Rheumatoid Arthritis

NCT03546335 is registered in ClinicalTrials.gov with Robert Flavell, MD, PhD as lead sponsor.

NCT NCT03546335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03546335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zirconium-89 Certolizumab PET Imaging in Patients With Rheumatoid Arthritis
Lead sponsor
Robert Flavell, MD, PhD
Phase
Phase 1
Overall status
Suspended
Start date
October 1, 2018
Completion date
March 31, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis